30 minutes
The biopharma industry is increasingly utilizing digital technologies and digital health tools that promise to modernize drug discovery and development, along with patient care and measurement of patient outcomes. There has been continued focus on supporting this convergence in Massachusetts, both within the leading academic institutions and government, but there’s still much more than can be done to build a sustainable community here. This panel will draw insights from other clusters on how to support better connectivity and collaboration between digital health and the life sciences.


Naomi Fried - CEO & Founder, Health Innovation Strategies
Stephen Bernstein - Co-Chair, Life Sciences Practice, McDermott, Will & Emery LLP
Thomas McCourt - President, Ironwood Pharmaceuticals
Name Audience
Conference Wide